                         SEQUENCE LISTING

<110>  Region Hovedstaden
 
<120>  Vaccine compositions comprising Tryptophan 2,3-dioxygenase or 
       fragments thereof

<130>  P3647PC00

<160>  20    

<170>  PatentIn version 3.5

<210>  1
<211>  406
<212>  PRT
<213>  homo sapiens

<400>  1

Met Ser Gly Cys Pro Phe Leu Gly Asn Asn Phe Gly Tyr Thr Phe Lys 
1               5                   10                  15      


Lys Leu Pro Val Glu Gly Ser Glu Glu Asp Lys Ser Gln Thr Gly Val 
            20                  25                  30          


Asn Arg Ala Ser Lys Gly Gly Leu Ile Tyr Gly Asn Tyr Leu His Leu 
        35                  40                  45              


Glu Lys Val Leu Asn Ala Gln Glu Leu Gln Ser Glu Thr Lys Gly Asn 
    50                  55                  60                  


Lys Ile His Asp Glu His Leu Phe Ile Ile Thr His Gln Ala Tyr Glu 
65                  70                  75                  80  


Leu Trp Phe Lys Gln Ile Leu Trp Glu Leu Asp Ser Val Arg Glu Ile 
                85                  90                  95      


Phe Gln Asn Gly His Val Arg Asp Glu Arg Asn Met Leu Lys Val Val 
            100                 105                 110         


Ser Arg Met His Arg Val Ser Val Ile Leu Lys Leu Leu Val Gln Gln 
        115                 120                 125             


Phe Ser Ile Leu Glu Thr Met Thr Ala Leu Asp Phe Asn Asp Phe Arg 
    130                 135                 140                 


Glu Tyr Leu Ser Pro Ala Ser Gly Phe Gln Ser Leu Gln Phe Arg Leu 
145                 150                 155                 160 


Leu Glu Asn Lys Ile Gly Val Leu Gln Asn Met Arg Val Pro Tyr Asn 
                165                 170                 175     


Arg Arg His Tyr Arg Asp Asn Phe Lys Gly Glu Glu Asn Glu Leu Leu 
            180                 185                 190         


Leu Lys Ser Glu Gln Glu Lys Thr Leu Leu Glu Leu Val Glu Ala Trp 
        195                 200                 205             


Leu Glu Arg Thr Pro Gly Leu Glu Pro His Gly Phe Asn Phe Trp Gly 
    210                 215                 220                 


Lys Leu Glu Lys Asn Ile Thr Arg Gly Leu Glu Glu Glu Phe Ile Arg 
225                 230                 235                 240 


Ile Gln Ala Lys Glu Glu Ser Glu Glu Lys Glu Glu Gln Val Ala Glu 
                245                 250                 255     


Phe Gln Lys Gln Lys Glu Val Leu Leu Ser Leu Phe Asp Glu Lys Arg 
            260                 265                 270         


His Glu His Leu Leu Ser Lys Gly Glu Arg Arg Leu Ser Tyr Arg Ala 
        275                 280                 285             


Leu Gln Gly Ala Leu Met Ile Tyr Phe Tyr Arg Glu Glu Pro Arg Phe 
    290                 295                 300                 


Gln Val Pro Phe Gln Leu Leu Thr Ser Leu Met Asp Ile Asp Ser Leu 
305                 310                 315                 320 


Met Thr Lys Trp Arg Tyr Asn His Val Cys Met Val His Arg Met Leu 
                325                 330                 335     


Gly Ser Lys Ala Gly Thr Gly Gly Ser Ser Gly Tyr His Tyr Leu Arg 
            340                 345                 350         


Ser Thr Val Ser Asp Arg Tyr Lys Val Phe Val Asp Leu Phe Asn Leu 
        355                 360                 365             


Ser Thr Tyr Leu Ile Pro Arg His Trp Ile Pro Lys Met Asn Pro Thr 
    370                 375                 380                 


Ile His Lys Phe Leu Tyr Thr Ala Glu Tyr Cys Asp Ser Ser Tyr Phe 
385                 390                 395                 400 


Ser Ser Asp Glu Ser Asp 
                405     


<210>  2
<211>  10
<212>  PRT
<213>  artificial sequence

<220>
<223>  Peptide fragment of human TDO

<400>  2

Arg Leu Leu Glu Asn Lys Ile Gly Val Leu 
1               5                   10  


<210>  3
<211>  10
<212>  PRT
<213>  artificial sequence

<220>
<223>  Peptide fragment of human TDO

<400>  3

Thr Leu Leu Glu Leu Val Glu Ala Trp Leu 
1               5                   10  


<210>  4
<211>  10
<212>  PRT
<213>  artificial sequence

<220>
<223>  Peptide fragment of human TDO

<400>  4

Phe Ile Ile Thr His Gln Ala Tyr Glu Leu 
1               5                   10  


<210>  5
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  Peptide fragment of human TDO

<400>  5

Leu Ile Tyr Gly Asn Tyr Leu His Leu 
1               5                   


<210>  6
<211>  10
<212>  PRT
<213>  artificial sequence

<220>
<223>  Peptide fragment of human TDO

<400>  6

Lys Leu Leu Val Gln Gln Phe Ser Ile Leu 
1               5                   10  


<210>  7
<211>  10
<212>  PRT
<213>  artificial sequence

<220>
<223>  Peptide fragment of human TDO

<400>  7

Lys Ile His Asp Glu His Leu Phe Ile Ile 
1               5                   10  


<210>  8
<211>  10
<212>  PRT
<213>  artificial sequence

<220>
<223>  Peptide fragment of human TDO

<400>  8

Leu Leu Lys Ser Glu Gln Glu Lys Thr Leu 
1               5                   10  


<210>  9
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  Peptide fragment of human TDO

<400>  9

Gln Leu Leu Thr Ser Leu Met Asp Ile 
1               5                   


<210>  10
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  Peptide fragment of human TDO

<400>  10

Gln Ile Leu Trp Glu Leu Asp Ser Val 
1               5                   


<210>  11
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  Peptide fragment of human TDO

<400>  11

Ser Ile Leu Glu Thr Met Thr Ala Leu 
1               5                   


<210>  12
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  Peptide fragment of human TDO

<400>  12

Leu Leu Ser Lys Gly Glu Arg Arg Leu 
1               5                   


<210>  13
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  Peptide fragment of human TDO

<400>  13

Asp Leu Phe Asn Leu Ser Thr Tyr Leu 
1               5                   


<210>  14
<211>  10
<212>  PRT
<213>  artificial sequence

<220>
<223>  Peptide fragment of human TDO

<400>  14

Lys Leu Glu Lys Asn Ile Thr Arg Gly Leu 
1               5                   10  


<210>  15
<211>  10
<212>  PRT
<213>  artificial sequence

<220>
<223>  Peptide fragment of human TDO

<400>  15

Leu Ile Pro Arg His Trp Ile Pro Lys Met 
1               5                   10  


<210>  16
<211>  10
<212>  PRT
<213>  artificial sequence

<220>
<223>  Peptide fragment of human TDO

<400>  16

Lys Met Asn Pro Thr Ile His Lys Phe Leu 
1               5                   10  


<210>  17
<211>  20
<212>  PRT
<213>  artificial sequence

<220>
<223>  Peptide fragment of human TDO

<400>  17

Val Ser Val Ile Leu Lys Leu Leu Val Gln Gln Phe Ser Ile Leu Glu 
1               5                   10                  15      


Thr Met Thr Ala 
            20  


<210>  18
<211>  20
<212>  PRT
<213>  artificial sequence

<220>
<223>  Peptide fragment of human TDO

<400>  18

Arg Phe Gln Val Pro Phe Gln Leu Leu Thr Ser Leu Met Asp Ile Asp 
1               5                   10                  15      


Ser Leu Met Thr 
            20  


<210>  19
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  Peptide fragment of HIVpol

<400>  19

Ile Leu Lys Glu Pro Val His Gly Val 
1               5                   


<210>  20
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  Peptide fragment of CMV pp65

<400>  20

Asn Leu Val Pro Met Val Ala Thr Val 
1               5                   


